[177Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases. - Belge Bilgin, Gokce; Bilgin, Cem; Burkett, Brian J.; Thorpe, Matthew P.; Packard, Ann T.; Fidanli, Fatma; Childs, Daniel S.; Muniz, Miguel; Orme, Jacob J.; Quevedo, J. Fernando; Kizilbash, Sani H.; Kwon, Eugene D.; et al. (European Journal of Nuclear Medicine & Molecular Imaging, 2026)